IMS Japan has provided unmatched insight and guidance to the
Japanese pharmaceutical and healthcare industries since 1964. A part of
IMS Health, founded in 1954 and operating in more than 100 countries,
IMS Japan first produced the Japan Pharmaceutical Market (JPM) audit in
1965 and has continued to offer high quality business intelligence and analysis,
evolved over the years, into a score of new products. With a long-standing
commitment to the industry, we offer solutions that help address the ongoing
challenges our
partners face.
IMS information covers an exceptional percentage of the Japanese
ethical pharmaceutical market. In addition, we have consulting experts focused
on understanding the global pharmaceutical sector, drawing on the knowledge
and worldwide data assets that are continually updated from 29,000 suppliers
at 225,000 sites, including drug manufacturers, retail and institutional
pharmacies, hospitals, wholesalers, prescribers and others. Our integrated
approach to collecting, analyzing and assessing information gives us a keen
understanding of the marketplace: what is being prescribed and when, how
it is being prescribed, and why.
IMS Japan values strong partnerships with our wholesalers,
clients, industry associations and other stakeholders. These relationships
are the cornerstone of our business, enabling us to gather critical industry
intelligence and deliver value added services back to our partners. IMS
solutions focus on speed, accuracy and in-depth coverage. Our strict quality
control guidelines ensure information is checked at every stage, guaranteeing
reliability, excellence and security.
Together, IMS and its partners are committed to creating
greater efficiencies in the Japanese pharmaceutical industry and contributing
to the delivery of improved healthcare in Japan.
Location
Main
0ffice
Toranomon Towers Office
4-1-28 Toranomon, Minato-ku
Tokyo 105-0001, Japan
Tel: 03-5425-9000
